Dosage Form Development, in Vitro Release Kinetics, and in Vitro–in Vivo Correlation for Leuprolide Released from an Implantable Multi-reservoir Array
- 27 March 2007
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 24 (7) , 1252-1261
Abstract
Implanted multi-reservoir arrays improve dosing control relative to osmotic pumps or polymer depots. The limited reservoir volume requires concentrated formulations. This report describes the development of a stable solid phase formulation of leuprolide acetate for chronic in vivo delivery from a multi-reservoir microchip and examines the correlation between in vitro release kinetics and serum pharmacokinetics. Concentrated formulations (>10% w/v) were prepared using small volume processing methods. Drug yield, release kinetics, and formulation stability were evaluated in vitro by HPLC. The correlation between in vitro and in vivo kinetic data was determined for a solid formulation by direct comparison of data sets and using absorption kinetics calculated from the Wagner–Nelson equation. High yield and the control of release kinetics by altering peptide formulation or reservoir geometry were demonstrated. Lyophilized leuprolide in a soluble solid matrix exhibited reproducible release kinetics and was stable (>95% leuprolide monomer) after 6 months at 37°C. A strong correlation was found between in vitro release kinetics and in vivo absorption by direct comparison of data sets and using the Wagner–Nelson absorption (slopes of 1.01 and 0.91; R2 0.99). Reproducible releases of a stable solid leuprolide formulation from a multi-reservoir microchip were achieved in vitro. Chronic pulsatile release was subsequently performed in vivo. Comparison of in vitro and in vivo data reveals that pharmacokinetics were controlled by the rate of release from the device.Keywords
This publication has 14 references indexed in Scilit:
- Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip deviceNature Biotechnology, 2006
- Electrothermally activated microchips for implantable drug delivery and biosensingJournal of Controlled Release, 2005
- Challenges for the oral delivery of macromoleculesNature Reviews Drug Discovery, 2003
- Where a Pill Won't ReachScientific American, 2003
- Time-programmed pulsatile release of dextran from calcium-alginate gel beads coated with carboxy-n-propylacrylamide copolymersJournal of Controlled Release, 2002
- Regulatory perspectives on in vitro (dissolution)/in vivo (bioavailability) correlationsJournal of Controlled Release, 2001
- Effect of peptide concentration and temperature on leuprolide stability in dimethyl sulfoxideInternational Journal of Pharmaceutics, 1999
- Catheter Survival During Long-Term Insulin Therapy With an Implanted Programmable PumpDiabetes Care, 1997
- Clinical Trial of Programmable Implantable Insulin Pump For Type I DiabetesDiabetes Care, 1992
- Per Cent Absorbed Time Plots Derived from Blood Level and/or Urinary Excretion DataJournal of Pharmaceutical Sciences, 1963